CSIMarket
 


Biospecifics Technologies Corp  (BSTC)
Other Ticker:  
 
 

BSTC's Net Income Growth by Quarter and Year

Biospecifics Technologies's Net Income results by quarter and year




BSTC Net Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 7.35 6.73 2.22
III Quarter September 5.39 6.27 5.04 2.71
II Quarter June 0.12 6.43 4.30 3.34
I Quarter March 4.50 4.42 3.98 2.92
FY   10.01 24.47 20.05 11.19



BSTC Net Income third quarter 2020 Y/Y Growth Comment
Biospecifics Technologies Corp reported fall in Net Income in the third quarter 2020 by -14.09% to $ 5.39 millions, from the same quarter in 2019.
The decline in the third quarter 2020 Biospecifics Technologies Corp's Net Income compares unfavorably to the Company's average Net Income jump of 41.43%.

Looking into third quarter 2020 results within Major Pharmaceutical Preparations industry 29 other companies have achieved higher Net Income growth. While Biospecifics Technologies Corp' s Net Income decrease of -14.09% ranks overall at the positon no. 1419 in the third quarter 2020.




BSTC Net Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - 9.21 % 203.15 % -27.21 %
III Quarter September -14.09 % 24.4 % 85.98 % 5.45 %
II Quarter June -98.13 % 49.53 % 28.74 % 18.02 %
I Quarter March 1.81 % 11.06 % 36.3 % 9.77 %
FY   - 22.04 % 79.18 % 0.72 %

Financial Statements
Biospecifics Technologies's third quarter 2020 Net Income $ 5.39 millions BSTC's Income Statement
Biospecifics Technologies's third quarter 2019 Net Income $ 6.27 millions Quarterly BSTC's Income Statement
New: More BSTC's historic Net Income Growth >>


BSTC Net Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - 17.22 % 33.53 % -18.08 %
III Quarter September 4388.84 % -2.49 % 17.21 % -18.86 %
II Quarter June -97.33 % 45.48 % 8.04 % 14.38 %
I Quarter March -38.78 % -34.32 % 79.28 % -4.26 %
FY (Year on Year)   - 22.04 % 79.18 % 0.72 %




Net Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #30
Healthcare Sector #115
Overall #1419

Net Income Y/Y Growth Statistics
High Average Low
209.14 % 41.43 % -98.2 %
(Mar 31 2015)   (Jun 30 2020)
Net Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #30
Healthcare Sector #115
Overall #1419
Net Income Y/Y Growth Statistics
High Average Low
209.14 % 41.43 % -98.2 %
(Mar 31 2015)   (Jun 30 2020)

Net Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Biospecifics Technologies's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
4551.81 % 152.94 % -97.43 %
(Sep 30 2020)  


BSTC's III. Quarter Q/Q Net Income Comment
Biospecifics Technologies Corp achieved in the III. Quarter 2020 above company average sequential Net Income doubling of 4388.84%, to $ 5.39 millions, from $0.12 millions in the second quarter.
BSTC is undergoing a remarkable growth, not only reporting better then average gain, but also accelerating pace, Erin  Wilson, Major Pharmaceutical Preparations industry expert from Glasgow added.

Within Major Pharmaceutical Preparations industry only one company achieved higher sequential Net Income growth. While Biospecifics Technologies's Net Income growth quarter on quarter, overall rank is 16.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #2
Overall #16
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #2
Overall #16
Net Income Q/Q Growth Statistics
High Average Low
4551.81 % 152.94 % -97.43 %
(Sep 30 2020)  


BSTC's III. Quarter Q/Q Net Income Comment
Biospecifics Technologies Corp achieved in the III. Quarter 2020 above company average sequential Net Income doubling of 4388.84%, to $ 5.39 millions, from $0.12 millions in the second quarter.
Biospecifics Technologies is undergoing a remarkable growth, not just reporting above average growth, and additionally improving rate.

Within Major Pharmaceutical Preparations industry only one company achieved higher sequential Net Income growth. While Biospecifics Technologies's Net Income growth quarter on quarter, overall rank is 16.


Biospecifics Technologies's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Net Income 12 Months Ending $ 17.36 $ 18.24 $ 24.55 $ 24.47 $ 23.85
Y / Y Net Income Growth (TTM) -27.22 % -19.35 % 19.82 % 22.02 % 53.48 %
Year on Year Net Income Growth Overall Ranking # 353 # 1112 # 499 # 305 # 1324
Seqeuential Net Income Change (TTM) -4.86 % -25.7 % 0.34 % 2.61 % 5.44 %
Seq. Net Income Growth (TTM) Overall Ranking # 1425 # 1540 # 760 # 761 # 595




Cumulative Net Income growth Comment
Biospecifics Technologies's cumulative 12 months Net Income continue to drop, but on the faster rate at -27.22% year on year, at Sep 30 2020 compare to the -19.35% decrease at Jun 30 2020. If the Biospecifics Technologies's fiscal year would end at Sep 30 2020, annual Net Income would be $17 millions.

In the Healthcare sector 38 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 353, from total ranking in previous quarter at 1112.

Net Income TTM Q/Q Growth Statistics
High Average Low
33.94 %
5.87 %
-25.7 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 33
Healthcare Sector # 39
Overall # 353

Net Income TTM Y/Y Growth Statistics
High Average Low
107.01 %
33.65 %
-27.22 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 116
S&P 500 # 1425
Cumulative Net Income growth Comment
Biospecifics Technologies's cumulative 12 months Net Income continue to drop, but on the faster rate at -27.22% year on year, at Sep 30 2020 compare to the -19.35% decrease at Jun 30 2020. If the Biospecifics Technologies's fiscal year would end at Sep 30 2020, annual Net Income would be $17 millions.

In the Healthcare sector 38 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 353, from total ranking in previous quarter at 1112.

Net Income TTM Q/Q Growth Statistics
High Average Low
33.94 %
5.87 %
-25.7 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 33
Healthcare Sector # 39
Overall # 353

Net Income TTM Y/Y Growth Statistics
High Average Low
107.01 %
33.65 %
-27.22 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 116
S&P 500 # 1425




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
BSTC's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for BSTC's Competitors
Net Income Growth for Biospecifics Technologies's Suppliers
Net Income Growth for BSTC's Customers

You may also want to know
BSTC's Annual Growth Rates BSTC's Profitability Ratios BSTC's Asset Turnover Ratio BSTC's Dividend Growth
BSTC's Roe BSTC's Valuation Ratios BSTC's Financial Strength Ratios BSTC's Dividend Payout Ratio
BSTC's Roa BSTC's Inventory Turnover Ratio BSTC's Growth Rates BSTC's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2020
Tenax Therapeutics Inc -0.15%$ -0.147 millions
Tactile Systems Technology Inc -0.29%$ -0.288 millions
Conmed Corporation-1.72%$ -1.722 millions
Mylan N v -2.16%$ -2.160 millions
Eli Lilly And Company-3.63%$ -3.629 millions
Baxter International Inc -4.27%$ -4.267 millions
Viemed Healthcare Inc -5.27%$ -5.270 millions
Icu Medical Inc-5.94%$ -5.937 millions
Emergent Biosolutions Inc -8.56%$ -8.565 millions
Bruker Corporation-10.08%$ -10.081 millions
3m Company-10.77%$ -10.768 millions
Innoviva Inc -11.54%$ -11.541 millions
Acadia Healthcare Company Inc -12.08%$ -12.082 millions
Biospecifics Technologies Corp-14.13%$ -14.129 millions
China Health Industries Holdings Inc -15.45%$ -15.449 millions
Encompass Health Corporation-16.23%$ -16.234 millions
Corcept Therapeutics Inc-17.90%$ -17.901 millions
Heartbeam Inc -18.94%$ -18.942 millions
Intuitive Surgical Inc -20.54%$ -20.542 millions
Utah Medical Products Inc-20.84%$ -20.837 millions
89bio Inc -22.01%$ -22.013 millions
Becton Dickinson And Company-22.09%$ -22.086 millions
Illumina Inc -23.50%$ -23.504 millions
Atrion Corporation-24.51%$ -24.513 millions
American Renal Associates Holdings Inc -24.90%$ -24.902 millions
Carlisle Companies Incorporated-25.82%$ -25.816 millions
Fonar Corporation-27.85%$ -27.852 millions
National Healthcare Corp-33.59%$ -33.588 millions
Msa Safety Incorporated-33.74%$ -33.740 millions
Zynex inc -34.43%$ -34.432 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com